Nxera Pharma Co Ltd
(FRA:JSS)
€
5.85
-0.15 (-2.5%)
Market Cap: 547.40 Mil
Enterprise Value: 746.31 Mil
PE Ratio: 0
PB Ratio: 1.52
GF Score: 74/100 Q2 2026 Nxera Pharma Co Ltd Earnings Presentation Transcript
Aug 07, 2026 / 08:00AM GMT
Release Date Price:
€4.62
(-1.70%)
Hironoshin Nomura
Nxera Pharma Co., Ltd. - Chief Financial Officer, Executive Vice President
(interpreted) It's time to start Nxera Pharma webinar for first half FY26 financial results.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot